ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
This Quarter Return
+2.96%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
AUM
$145M
AUM Growth
+$145M
Cap. Flow
-$41.7M
Cap. Flow %
-28.69%
Top 10 Hldgs %
61.57%
Holding
40
New
11
Increased
4
Reduced
15
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MCRB icon
26
Seres Therapeutics
MCRB
$166M
$1.51M 1.04% +63,259 New +$1.51M
VERV
27
DELISTED
Verve Therapeutics
VERV
$1.49M 1.03% +24,790 New +$1.49M
RGLS
28
DELISTED
Regulus Therapeutics
RGLS
$1.18M 0.81% 1,450,777 -534,695 -27% -$435K
BLSA
29
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$877K 0.6% 83,277 +900 +1% +$9.48K
GLTO icon
30
Galecto
GLTO
$4.21M
$308K 0.21% 60,968 -52,547 -46% -$265K
KURA icon
31
Kura Oncology
KURA
$686M
-277,468 Closed -$7.84M
RCUS icon
32
Arcus Biosciences
RCUS
$1.13B
-236,494 Closed -$6.64M
SAGE
33
DELISTED
Sage Therapeutics
SAGE
-79,650 Closed -$5.96M
UNH icon
34
UnitedHealth
UNH
$281B
-29,357 Closed -$10.9M
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$100B
-53,855 Closed -$11.6M
SEEL
36
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-440,745 Closed -$2.2M
RNLX
37
DELISTED
Renalytix plc American Depositary Shares
RNLX
-160,969 Closed -$4.13M
NSTG
38
DELISTED
NanoString Technologies, Inc.
NSTG
-142,530 Closed -$9.37M
JNCE
39
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-520,858 Closed -$5.35M
TPTX
40
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-11,873 Closed -$1.12M